Member Info for sharehead

No, afraid not. This was rising well, and could easily do so again, i have seen this share drop, drop, drop and then reverse and shoot up as funds add again, and have seen it shoot up and reverse down. Clearly the news that pharmas have requested more trials and further info on regulatory paths hit sentiment in a big way but really, this is trading just above its cash holdings now. The potential is still there, this could still be massive, just like all things its not a straight road. Still that may now have thrown up a huge opportunity here, we'll see.

Surely this is well oversold now. Mcap of 25 million, cash in bank of 21 million. Low R&D now has meant low cash burn and news due that could see the down trend reverse. Interesting.

IIs and other funds start to BUY and build whilst the delay has turned this into a bit of a bargain.

Just checked Neil Woodford's fund holds 33% of the company. If news on masking discussions noted below is positive as suggested then surely mcap should be circa 40 million at least, plus cash - i.e. at least double what it currently is. Then just need further product updates.

Oxp has cash of over £22 million plus a rebate of 0.75 million due so is very well funded. Mcap currently 34 million so is the company only worth £11 million over the cash position. As noted below Neil Woodford holds a major position here. News on masking due soon ? This sp has been over 10p and dropped as potential JV partners want products further developing before committing - so they are still open to committing, just not yet. This was 7p before these talks even started i think. Also... During discussions with prospective partners, it has also become clear that in OTC markets, the taste masking benefits of the OXPZeroTM technology are of significant interest. There are multiple opportunities in this area including taste masked non-tablet products for cough & cold remedies and taste masked formulations for pain & fever, all areas in which paracetamol based formulations currently dominate because of the ease of masking the taste of paracetamol and where it is not currently viable to incorporate ibuprofen or naproxen. The Company is currently involved in on-going partnership discussions for these applications of its OXPZeroTM technology and will update shareholders in due course.

Looks like the other parties just kicked the can down the street until the new post brexit regulatory route become clearer. Shame. Still will come good Imo.

I think this is a bargain entry level and this could easily rocket from these levels. Look at the list of IIs that hold here on the companies website and how little free float is available, news grows closer and the article posted below shows the ever growing potential imo.

Oops, mean 5.15 and 5.20 all BUYs : - ))

Been checking prices this afternoon and the 3.15,s and 3.20 are BUYs.

Entry / top levels Imo, agree potential wise this is one of the best shares around Imo.

This looks a total bargain again !

Multibagged out of nowhere. Seems to drift down, like now, then pull good news out of the bag. Seen it go from here to 0.4p in weeks. Money raised recently, profitably improved, new clients and more repeat business.... Could be a good time to BUY and tuck away Imo, will keep watching.

Lots of Institutional Investors are already in here, but by getting the message out to others for whom OXP is still off radar will only serve to reduce the already very low free float which in turn can push the sp higher, we in here see 25p as our first target. In terms of news the RNSs clearly document the journey we are on and the massive market they expect to open up. If even more background BUYing kicks in following presentations then all the better, let them fight over the tiny free float !

..... imo. Wonder which further Instutional Investor will pop up next to add to the long existing list ?

I have said before there are very few shares in free float. Lots of institutional investors already hold big here and senior staff majority options kick in at 50p. Believe other IIs will be trying to build holdings here. So sp rises with background BUYs and some MMs hitting stop losses for more shares imo, as well as raising sp as don't want to sell too many too cheaply, again imo. IIs held firm i believe based on the list of major holders when this went to 12 to 13p i can only assume in anticipation of much higher rewards here.

Wonder if yesterday took out stop losses to fill some of todays BUYs incl that 250k BUY. Not selling any of mine till much higher levels which i'm confident we will see. Gla.

Lots of Institutions hold here, look on the web site list, incl. Neil Woodford. If someone getting orders filled and no one selling by choice, did MM' s take out some stop losses to collect more shares to sell ?

Probably an II. Double figures here soon I think

We know majority of senior staff share options are set at 50p and Neil Woodford and all the IIs here held strong at the last peak of 12p to 13p so with product news progressing wonder what next peak could be ?

Think this should be a good riser